Skip to main content Skip to main navigation Skip to search Skip to footer

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

The science of genomics is at the beginning of a new era of innovation. Today, a human genome can be sequenced in a few hours and for a few thousand dollars; a task that took 13 years and USD 2.7 billion to accomplish during the Human Genome Project. Next Generation Sequencing (NGS) has revolutionized the way we carry out biological research today. The applications of NGS seem endless; various applications of the technology in the fields of science such as cancer research, disease diagnosis, biofuels, marine sciences, livestock research, agricultural, and veterinary research drive the NGS market. Another important driver of the sector is to provide cheaper sequencing possibilities for needing patients in the provider universe. Advances in the next-generation sequencing technology have opened the door to leveraging genomics in personalized medicine and clinical trials.

DOWNLOAD THE WHITEPAPER

Kontaktieren Sie uns
MAX CHARACTERS: 10,000

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.